PLATINUM for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where PLATINUM was used for Lung neoplasm malignant.
Most Reported Side Effects for PLATINUM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 43 | 13.1% | 5 | 9 |
| Off label use | 29 | 8.8% | 3 | 13 |
| Fatigue | 27 | 8.2% | 6 | 9 |
| Metabolic disorder | 24 | 7.3% | 0 | 0 |
| Thrombocytopenia | 24 | 7.3% | 1 | 4 |
| Pneumonitis | 23 | 7.0% | 4 | 6 |
| Anaemia | 22 | 6.7% | 2 | 4 |
| Malignant neoplasm progression | 22 | 6.7% | 7 | 6 |
| Neutropenia | 22 | 6.7% | 1 | 1 |
| Blood lactate dehydrogenase increased | 20 | 6.1% | 0 | 0 |
| Hepatitis b core antibody positive | 15 | 4.6% | 0 | 0 |
| Diarrhoea | 14 | 4.3% | 4 | 4 |
| Nausea | 14 | 4.3% | 1 | 1 |
| Vomiting | 14 | 4.3% | 4 | 5 |
| Acute kidney injury | 13 | 4.0% | 1 | 4 |
Other Indications for PLATINUM
Non-small cell lung cancer (58)
Product used for unknown indication (41)
Non-small cell lung cancer metastatic (18)
Plasma cell myeloma (18)
Osteosarcoma (15)
Lung adenocarcinoma (14)
Small cell lung cancer (11)
Lymphoma transformation (9)
Non-hodgkin's lymphoma (9)
Diffuse large b-cell lymphoma refractory (8)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)